Spencer Smith, PhD, received one of 36 NSF grants to create better technologies to advance our knowledge of how the brain works in normal circumstances and in disease states.
The Bamberg Diabetes Transitional Care Study will utilize cutting-edge iPad technology to explore the impact and feasibility of different diabetes interventions for patients transitioning from the hospital to home.
More than half of patients 65 and older were either malnourished or at risk for malnutrition, study finds.
The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center, UNC-Chapel Hill and other TCGA sites, revamps traditional ideas of how cancers are diagnosed and treated and could also have a profound impact on the future landscape of drug development.
This study is believed to be the first to measure attitudes toward e-cigarettes among physicians treating adult smokers.
The finding, detailed in the new journal eLife, shows how the protein GSK-3 is essential for neuronal migration and could be a key player in neurodevelopmental disorders.
Several members of the UNC School of Medicine faculty had articles published in the Journal of the American Medical Association's (JAMA) July 23/30, 2014, HIV/AIDS theme issue.
The grant will allow UNC researchers, led by Samuel McLean, MD, MPH, to perform the first-ever prospective longitudinal study of health outcomes after sexual assault. Graduate students, fellows, or faculty from underrepresented racial and ethnic groups who are interested in potentially developing an NIH Diversity Supplement application related to the study are invited to send a cover letter to the program manager.
By eliminating specific foods from patients’ diets, symptoms improved in 71 percent of patients.
UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.
The nonprofit organization Alzheimer’s North Carolina, Inc., has awarded a $130,000 grant to launch a new collaborative effort by the UNC School of Medicine, Duke University and other academic research institutions to join forces in the race to prevent and cure Alzheimer’s disease.
Henrik Dohlman, PhD, discovered why seemingly identical cells might react differently to the chemical signals inside our bodies and the drugs we use to battle diseases.
UNC researchers lay the groundwork for a new approach to brain cancer treatments and a better understanding of Parkinson’s disease.
Genes, pathways identified could inform new approaches to treatment
Andrew Dudley, PhD, assistant professor of cell biology and physiology, was recently named an American Cancer Society Research Scholar. His funded research proposal will investigate “Mechanisms of tumor escape from anti-angiogenic therapy.”
Eliminating an enzyme known as factor XIII shrinks clots by 50 percent. The discovery could lead to a safer alternative to blood thinners for patients at high risk of deep vein thrombosis.
Though cancer screening has come a long way, physicians still do not thoroughly discuss with patients the advantages and disadvantages of these procedures before decisions are made to undergo the screenings, according to a new study co-authored by a UNC physician.
A new article, authored by William A. Rutala, PhD, MPH, and David J. Weber, MD, MPH, explains five key considerations that health care professionals should take into account when selecting the optimal disinfectant for decontamination of environmental surfaces.
The goal of this study is to measure the effects of an investigational drug on social behavior, communication, and safety. Study for adult males, ages 18-45, with high functioning autism.
Maya Styner, MD, unveils a new kind of study showing how a high-fat diet, exercise, and diabetes medications can change the insides of our bones.